@article{ref1,
title="Lead and hyperactivity. Behavioral response to chelation: a pilot study",
journal="American journal of psychiatry",
year="1976",
author="David, O. J. and Hoffman, S. P. and Sverd, J. and Clark, J. and Voeller, K.",
volume="133",
number="10",
pages="1155-1158",
abstract="Lead-chelating medication was used to treat 13 hyperkinetic school children whose blood and urine lead levels were in an elevated but &quot;nontoxic&quot; range. Six children with histories of etiologically relevant perinatal or developmental complications showed relatively little improvement. Seven other children with unremarkable histories, and for whom a lead etiology could thus be entertained, showed marked improvement. The authors conclude that lead may play an important role in the etiology of some cases of hyperactivity; lead-chelating agents may have a major place in the treatment of hyperactivity; and the medical workup of hyperactivity should include lead level measurements and careful consideration of other possible etiological factors.<p /><p>Language: en</p>",
language="en",
issn="0002-953X",
doi="",
url="http://dx.doi.org/"
}